Treatment of anxiety and depression in cancer patients using intergtaive medicine

Updates from ASCO 2024 in gastrointestinal tumours

Research highlights in breast cancer

GIST tumours and soft tissue sarcomas

Hormonal receptor positive breast cancer adjuvant and metastatic indications

Antibody drug conjugates coming to primetime and new agents for breast cancer

Intervention of osteoclastogenesis that occurs in breast cancer and multiple myeloma

Uncommon genetic aberrations NTRK, RET, NRG

Updates on triple negative breast cancer and immunotherapy

Pembrolizumab combined with xelox and bevacizumab shows higher efficacy than standard therapeutic regimen in mCRC

Paclitaxel and ramucirumab switch maintenance therapy prolongs survival in HER2-negative advanced GEJ cancer

Glofit-GemOx shows clinically meaningful benefit in relapsed/refractory diffuse large B-cell lymphoma